Development, marketing and sales of pharmaceutical products.
The company is 5 years old. 2 legal entities (Ukraine / Estonia). The company is at the stage of scaling. Sales: 2nd year ~ 20,000 USD, 3rd year ~ 100,000 USD, 4th year ~ 300,000 USD. The planned increase of the company's value from 2022 to 2030 is 7-14 times. The planned amount of dividends is 11-25% per annum.
Annual sales, $
Annual net income, $
Property and assets
Tangible assets: goods, raw materials, electronic and office devices. Intangible assets: trademarks, technical documentation, web-sites and social media
Number of employees
Problem or Opportunity
For each our product there is a market segment (capacity specified in the presentation).
Solution (product or service)
More information about the products - in the presentation.
The main competitors are the TOP-50 companies of the pharmaceutical market of Ukraine (TOP-20 in the dietary supplement segment).
Advantages or differentiators
Six of the twelve main products have unique differences and have no direct complete analogues at market.
The cost of products and sales forecasts - in the presentation.
Sales channels - national pharmaceutical distributors, national and local pharmacy chains. We currently have contracts with all major national pharmaceutical distributors, and our products are in the TOP-20 networks of Ukraine.